Clinical Trial

BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This research study aims to examine biomarkers of Alzheimer's disease as early as possible which could potentially be a screening tool for the general population. This observational study will take place at the Memory and Aging Program at Butler Hospital. The study will enroll up to 200 cognitively healthy subjects aged 50 to 80 years with ongoing recruitment and enrollment for 2 years, and subject participation lasting approximately 4 years. Disclosure of AD risk assessments will be an optional procedure. Two PET imaging sub-studies will also be optional.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-07-11; most recent amendment 2024-12-13.
Status change: Recruiting → Enrolling by Invitation 2024-12-13
Status change: Not Yet Recruiting → Recruiting 2023-03-02
Trial Details
NCT Number NCT05457998
Lead Sponsor Butler Hospital
Collaborators: The Warren Alpert Foundation, Brown University, University of Rhode Island, Hoffmann-La Roche, Eli Lilly and Company, GE Healthcare
Conditions Alzheimer Disease, Mild Cognitive Impairment, Dementia
Enrollment 200 participants
Start Date 2023-06-14
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2024-12-17